Analysis of the DepMap data of glioma cell lines revealed a correlation between elevated FOSL1 expression and unfavorable TMZ response in GBM, which aligns with recent findings that highlight FOSL1 as a transcription factor involved in oncogenesis and chemoresistance in breast cancer and melanoma [19, 35]. The gene discussed is FOSL1; the disease is breast carcinoma.